Janome Prices the Scar, Not the Shrink

Summary: 6445.T traded at JPY 1,208 at 09:19 JST on May 28, 2026, which still leaves Janome on only 0.59x book, 10.14x trailing EPS, and a 4.97% indicated dividend yield, even though the company already finished a 1,149,400-share buyback and will cancel 1,129,400 of those shares on May 29, 2026. Management is also guiding FY2027 net profit to rise to JPY 2.0 billion from JPY 590 million and the annual dividend to double to JPY 60 from JPY 30. The tape is still pricing Janome like the old profitability scar is the whole story. The filings say the denominator is about to get smaller and the earnings base is supposed to get better at the same time. [1][2][3][4]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Near-Term >5% Move Case	Asymmetry	Main Reason to Reject
1	Janome prices the scar, not the shrink	Japan / TSE Prime / mid cap / treasury cancellation / capital return / Japan override	`6445.T` was JPY 1,208 at 09:19 JST on May 28, still only 0.59x book, even though Janome completed a 1,149,400-share buyback by April 9 and will cancel 1,129,400 shares on May 29. Management also guided FY2027 net profit to JPY 2.0 billion and the annual dividend to JPY 60. [1][2][3][4]	High. Live quote checked in this run. Cancellation filing is dated May 12, 2026 and the buyback-completion notice is dated April 10, 2026. [1][2][3]	High. The cancellation is scheduled for May 29, 2026. [3]	A move above 5% only requires the market to carry today's 0.59x reported P/B onto the post-cancellation share count. That points to roughly JPY 1,290, or about +6.8%. Evidence quality is medium-high because the date is hard and the math is visible. [1][3]	High. The stock is already cheap on reported book and even cheaper on pro forma book.	Selected.
2	Mgame still trades like game beta, not canceled stock	Korea / KOSDAQ / mid cap / gaming / buyback-to-cancel	`058630` was KRW 4,730 at 10:34 KST on May 28, with 0.63x P/B and 6.29x P/E, while the board-backed KRW 2.0 billion repurchase program for 411,100 shares runs through August 14, 2026 and is meant to be followed by cancellation. [5][6]	High. Live quote checked in this run; buyback terms are current to mid-May 2026. [5][6]	Medium. The repurchase window lasts until mid-August. [6]	A >5% move is plausible if investors start capitalizing the cancellation instead of the stale game narrative, but the clock is softer and slower than Janome's next-day cancellation.	Moderate. Cheap enough to work, but the denominator change is smaller and less immediate.	The window is too long and the rerating depends more on sentiment than on a dated accounting reset.
3	Teitwo still trades below its own `ToSTNeT-3` print	Japan / TSE Standard / compliant sub-`JPY 800` small cap / completed buyback	`7610.T` was JPY 132 at 10:53 JST on May 28, still below the JPY 134 price where the company bought back 1,852,000 shares on May 20, 2026. [7][8]	High. Live quote checked in this run; buyback result is dated May 20, 2026. [7][8]	Weak. The main event already happened. [8]	A >5% move is possible because the stock is illiquid and low priced, but there is no equally hard second calendar event now. Evidence quality is low-medium.	Low-moderate. The price is cheap, but the setup has already spent its best mechanical catalyst.	The first act is over and there is no fresh forcing mechanism.

Selected opportunity: Janome Corporation (6445.T)

Why this one now: Janome is the strongest unpublished setup I could verify in the user-scoped Japan, Korea, Hong Kong, Taiwan, and Singapore screen where a hard corporate-action date still collides with a valuation discount. Mgame is optically cheaper on P/E and still valid, but the cancellation path runs into August. Teitwo respects the sub-JPY 800 Japan filter, but its best event is already in the tape. Janome gives a live quote, a next-day cancellation, and a visible per-share book-value reset in one package. [1][3][5][6][7][8]

Why it can jump or dump more than 5% soon: At JPY 1,208, Janome trades on about 0.59x reported book value of JPY 2,063.20 per share. If the market simply holds that same multiple after 1,129,400 shares are canceled on May 29, pro forma book value rises to roughly JPY 2,200 per share and the stock maps to about JPY 1,290, or +6.8%. The bear path is just as real: if investors decide the cancellation is already known and the FY2027 guide is too optimistic, the stock can fall back toward the JPY 1,089 year low. [1][3]

What should surprise the reader: The stock is already on 0.59x book before the cancellation. After the cancellation, the same market price implies roughly 0.55x pro forma book, even while management is guiding a 238.8% jump in net profit and a doubled dividend. The market is still trading the scar. The denominator is changing tomorrow. [1][3][4]

Japan, Korea, Hong Kong, Taiwan, Singapore Scope Audit

This run was explicitly scoped by the user to Japan, Korea, Hong Kong, Taiwan, and Singapore low/mid caps, so I did not widen the screen to the U.S. or Europe.

Japanese local-language search used: 自己株式の消却 5月29日東証中型株, 低PBR 自己株 ToSTNeT-3 800円以下, ジャノメ自己株式消却, テイツー ToSTNeT-3.
Korean local-language search used: 자사주 취득 후 소각 중소형주, 엠게임 자사주 소각, 저PBR 코스닥 자사주.
Traditional Chinese search used for Hong Kong and Taiwan: 子公司上市母公司折讓港股, 現金減資庫藏股上櫃中小型股.
Singapore search used: mandatory-offer, scheme, and capital-return screens for small and mid-cap SGX names.
Japan low-price priority respected: I explicitly ranked a compliant sub-JPY 800 Japan name, Teitwo, and re-checked other low-price Japanese buyback candidates during the screen. They failed because their best mechanical events were already spent. [7][8]
Why the Japan override still won: Janome is above the preferred JPY 800 threshold, so this is a deliberate Japan override. It beat the best compliant Japan candidate because Teitwo lacks a second hard event, and it beat the best Korea finalist because Mgame's cancellation clock is slower and less discrete. [1][3][5][6][7][8]

The Setup

Janome is not a concept stock. It sells sewing machines, industrial equipment, and related products. That ordinary profile is the point. Stocks like this do not need heroic narratives. They need a reason for investors to stop anchoring on old disappointment. [4]

Janome now has two.

First, the company finished buying back 1,149,400 shares for JPY 1,496,083,500 by April 9, 2026. [2]

Second, the board will cancel 1,129,400 treasury shares on May 29, 2026, reducing issued shares from 18,108,605 to 16,979,205. [3]

At the same time, management's FY2027 plan calls for revenue of JPY 42.0 billion, operating profit of JPY 1.8 billion, ordinary profit of JPY 1.95 billion, and net profit of JPY 2.0 billion, versus FY2026 results of JPY 38.336 billion, JPY 788 million, JPY 1.004 billion, and JPY 590 million. The annual dividend is planned to rise to JPY 60 from JPY 30. [4]

The market is still looking backward. The live quote says JPY 1,208, 0.59x P/B, and only JPY 21.875 billion of market capitalization. [1]

The Mispricing

Confirmed facts

Janome was JPY 1,208 at 09:19 JST on May 28, 2026, with 0.59x P/B, 10.14x trailing P/E, 4.97% indicated yield, JPY 21.875 billion market cap, and a 52-week range of JPY 1,089 to JPY 1,483. [1]
The company completed a 1,149,400-share repurchase by April 9, 2026. [2]
It will cancel 1,129,400 shares on May 29, 2026, cutting issued shares by about 6.2%. [3]
Management is guiding FY2027 net profit to JPY 2.0 billion from JPY 590 million and raising the planned annual dividend to JPY 60 from JPY 30. [4]
The same presentation states medium-term targets of ROE above 8% and PBR above 1.0x. [4]

What the market appears to be pricing

The tape still looks like a stock investors file under ordinary, low-ROE Japan machinery: too dull to pay for, too weak historically to trust, and too well-known for a cancellation notice to matter.

What the market may be missing

The next-day cancellation changes the denominator in a stock that is already below book. At today's quote, reported book is JPY 2,063.20 per share. Adjusting only for the lower share count lifts pro forma book to roughly JPY 2,200 per share. The market does not need to believe Janome deserves 1.0x book. It only needs to stop valuing post-cancel Janome at a lower multiple than pre-cancel Janome. [1][3]

Why the market may still be right

The strongest pushback is not hard to state. FY2026 profit was weak, Janome's business mix is unglamorous, and a 6.2% cancellation may not fix a company that still has to prove its earnings rebound. If investors think the FY2027 plan is a hope note rather than a base case, the discount can persist.

Price

Market Level	Value	Timestamp / Source	Why It Matters
Spot price	JPY 1,208	Yahoo Finance Japan, 2026-05-28 09:19 JST [1]	Live entry reference for this run
One-day change	-JPY 8, -0.66%	Same live quote check [1]	The stock is not being chased into the cancellation
Market cap	JPY 21.875 billion	Same live quote check [1]	Confirms this is a Japan mid-cap, not a micro-cap
Trailing P/E	10.14x	Same live quote check [1]	Cheap enough, but not the core valuation anchor
P/B	0.59x	Same live quote check [1]	Core valuation gap
BPS	JPY 2,063.20	Same live quote check [1]	Base for the pro forma book-value math
Forward dividend yield	4.97%	Same live quote check [1]	Management is asking the market to pay for a much larger payout
52-week high / low	JPY 1,483 / JPY 1,089	Same live quote check [1]	Shows the rerating has not happened
Buyback completed	1,149,400 shares, JPY 1.496 billion	Official completion notice dated April 10, 2026 [2]	Confirms management already spent real cash
Cancellation effective date	May 29, 2026	Official cancellation notice dated May 12, 2026 [3]	Hard catalyst date
Shares outstanding after cancellation	16,979,205	Same cancellation notice [3]	Drives the pro forma book-value reset
FY2027 net profit / dividend plan	JPY 2.0 billion / JPY 60	FY2026 results and FY2027 plan dated May 12, 2026 [4]	Puts a profit rebound and a doubled payout next to the cancellation

I am not using technicals as the thesis. As timing context only, the stock is still much closer to the JPY 1,089 year low than to the JPY 1,483 high. That is consistent with a market that has not rerated the capital-return story yet. [1]

Positioning

This is not a squeeze trade.

What I can verify:

Yahoo Finance Japan showed 14,900 margin shorts against 98,700 margin longs, for a margin ratio of 6.62x, with the latest update dated May 22, 2026. [1]
The same live quote page showed only 2,000 shares traded at the moment of the check. [1]
The company itself has been the visible buyer through the completed repurchase program. [2]

What I cannot verify in this run:

Borrow cost.
A liquid listed single-stock options chain.
Holder-by-holder institutional positioning.

So the positioning claim should stay narrow. Janome looks under-owned and illiquid, not crowded.

Catalyst

Catalyst 1: The cancellation date is immediate. The company does not merely have a buyback authorization. It has a dated cancellation on May 29. [3]

Catalyst 2: The per-share book-value math gets cleaner. If investors update for the lower share count, pro forma book rises to roughly JPY 2,200 per share from the current JPY 2,063.20 base. [1][3]

Catalyst 3: The payout step-up is already on the table. Management plans an annual dividend of JPY 60, double the prior JPY 30. [4]

Catalyst 4: The earnings bar is low. The stock does not need perfection. It needs the FY2027 rebound plan to remain intact long enough for the market to stop valuing it like dead capital. [4]

Payoff Map

This is a long common-stock setup.

Facts: Janome is live at JPY 1,208, below book, about to cancel 1,129,400 shares, and guiding a much better FY2027 than the just-finished FY2026. [1][3][4]

Inference: The market is still anchoring on the old earnings scar rather than on the combination of denominator shrink and higher payout.

Reasonable but not yet verified judgment: A rerating to even 0.59x of pro forma book value, which is merely today's reported multiple on a smaller share count, points to about JPY 1,290. That is the base case, not the stretch case. [1][3]

Trade expression: Own Janome common stock (6445.T). I rejected options because I did not verify a usable listed-options chain in this run, and the trade is about a slow accounting rerating rather than a binary one-session gap.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	25%	JPY 1,400	+15.9%	2 to 8 weeks	The market carries Janome to roughly 0.64x pro forma book, helped by the cancellation, dividend reset, and continued confidence in the FY2027 plan.	Medium
Base Case	50%	JPY 1,290	+6.8%	1 to 6 weeks	Investors simply reapply today's 0.59x reported P/B to the post-cancellation share count.	Medium-High
Bottom Case	25%	JPY 1,110	-8.1%	1 to 6 weeks	The cancellation is ignored, the FY2027 plan is treated as too optimistic, and the stock drifts back toward the lower end of the yearly range.	Medium
Invalidation / Stop Condition	n/a	Below JPY 1,080 on a closing basis	n/a	Immediate on trigger	A decisive break of the yearly low area or new disclosures that materially weaken the FY2027 recovery case.	Medium

Probability-weighted expected value: JPY 1,272.5, about 5.3% above the live reference price.

Current market price / level: JPY 1,208. [1]

Timestamp: 2026-05-28 09:19 JST. [1]

Primary instrument: Janome Corporation common stock (6445.T).

Alternative expressions considered: Waiting until after the cancellation prints through the tape, or avoiding the stock because the business is too ordinary. Both are cleaner emotionally. Both risk paying up if the market rerates on the denominator reset first.

Confidence: Medium.

What Would Prove This Wrong

This thesis breaks in three ways.

The market is right that Janome's earnings quality and business mix deserve a persistent deep discount, even after the share count shrinks.
The FY2027 plan starts to look unrealistic, especially on margin recovery or payout sustainability.
The cancellation happens and the stock still cannot hold above the low JPY 1,100s, which would mean the market is treating the action as fully priced or irrelevant.

If the stock closes below JPY 1,080 on fresh company-specific information, the cleaner read is that the old scar still dominates the new math.

Risk Audit

Strongest counterargument: Janome is not mispriced. It is a fair-value low-ROE machinery stock where a 6.2% cancellation is too small to change the long-term economics, and where management's PBR above 1.0x target is aspiration, not evidence. [3][4]

Most fragile assumption: That investors will quickly translate the lower share count into a higher fair value rather than wait for more proof on margins and orders.

What the market may already know: All of the key facts are public. The edge is not hidden information. It is the possibility that the market is underweighting how cheap the stock already is before the cancellation becomes effective.

What could make the trade lose money even if the thesis is directionally right: Time and inertia. Ordinary Japan industrial names can stay cheap for longer than the math seems to justify.

Liquidity / execution risks: Real. Volume at the moment of the quote check was only 2,000 shares. Use limit orders only. [1]

Leverage risks: Poor fit. This is not a setup for forced sizing.

Information reliability risks: Core facts come from the live quote page and official company disclosures. The uncertain part is not the cancellation. It is how quickly the market will care. [1][2][3][4]

Invalidation trigger: A stock-specific close below JPY 1,080, or new disclosures that materially weaken the FY2027 rebound and payout path.

Publish / revise / reject recommendation: Publish. The disagreement is specific, current, and mechanically testable.

Bottom Line

Janome does not need a glamorous narrative. It needs investors to stop valuing a post-cancellation stock on pre-cancellation complacency. At JPY 1,208, the market is still paying only 0.59x reported book for a company that will shrink the share count tomorrow, double the dividend plan, and ask investors to believe in a materially better FY2027. The market may still be right to doubt the recovery. It is not obvious the market should doubt it this much.

Best Trade Strategy

Direction: Long

Preferred instrument: Janome Corporation common stock (6445.T)

Common-stock stance: Preferred. The thesis is about denominator reset plus modest rerating, not about extreme convexity.

Options stance: insufficient live data. I did not verify a liquid Janome single-stock options chain in this run, so this should be treated as a cash-equity idea only.

Entry reference: Around JPY 1,208, the live quote checked at 09:19 JST on May 28, 2026. [1]

Take-profit framework: First trim zone around JPY 1,290. Full-thesis zone around JPY 1,400 if the market starts valuing Janome closer to 0.64x pro forma book and the FY2027 recovery plan holds.

Stop-loss / invalidation: Reassess hard on any stock-specific close below JPY 1,080 or on new guidance that materially weakens the FY2027 profit and dividend plan.

Time horizon: Now through the May 29, 2026 cancellation and the following 1 to 6 weeks of tape adjustment.

Execution risks: Thin liquidity, event-day gap risk, and no verified options liquidity. Use limit orders only and size for a mid-cap Japan tape, not for a liquid large cap.

Do-not-trade conditions: Do not chase a gap of more than 10% without fresh filing-based evidence. Do not use leverage. Do not treat this as a pure dividend capture.

Monitoring checklist:

Confirm the cancellation becomes effective on May 29, 2026. [3]
Re-check whether the stock can hold above JPY 1,200 after the cancellation.
Watch for any revision to the FY2027 profit or dividend plan. [4]
Re-check liquidity before every order.

Research Quality Scorecard

Criterion	Score	Evidence Note
Market disagreement	5	The disagreement is specific: a sub-book tape versus an immediate 6.2% share cancellation plus a doubled dividend plan. [1][3][4]
Evidence base	5	Core facts come from a live quote check and official company filings. [1][2][3][4]
Positioning and flows	3	Margin data and thin tape are usable, but borrow and institutional holder data were not verified. [1]
Catalyst path	5	The cancellation date is explicit: May 29, 2026. [3]
Payoff architecture	4	The base case only requires reapplying today's multiple to a smaller share count. Downside is anchored to the yearly low area. [1][3]
Invalidation discipline	4	A close below JPY 1,080 or a meaningful weakening of the FY2027 recovery case would break the thesis.
Differentiated insight	5	The non-obvious point is that Janome is already on 0.59x book before the cancellation, which implies roughly 0.55x pro forma book after it. [1][3]
Client value	5	Useful even without taking the trade because it shows how to underwrite a Japan cancellation setup without pretending the business is better than it is.

Total Score: 36 / 40

Verdict: Publish-ready Deep Dive Trade Note

Sources

Illustration Prompt

Create a realistic, high-value, high-end editorial cover image for The Mispricing Desk about Janome in late May 2026. The scene should feel like a quiet Japanese boardroom after a capital-allocation decision, not a trading floor. In the foreground, place a stack of retired share certificates being fed into a precise paper-cutter or shredder marked May 29, with a smaller ledger showing 0.59x P/B, JPY 1,208, and 16,979,205 shares after cancellation. Beside it, place a neatly folded dividend notice stamped JPY 60, contrasted against an older, faded slip marked JPY 30. In the background, show a sewing machine and an industrial precision machine in cool steel tones, suggesting Janome's ordinary business reality, while a translucent book-value ledger glows faintly behind them like an ignored balance sheet. Mood: forensic, elegant, expensive, skeptical. Palette: graphite, brushed steel, ivory paper, muted navy, and restrained crimson accents. No generic green candlesticks, no rockets, no meme-finance imagery. Include a subtle but clear watermark reading The Mispricing Desk.